Lana Medical Co. (9587) is listed on Nomu of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Lana Medical Co. reported revenue of SAR 92M, net profit of SAR 3M, and earnings per share of SAR 0.05. Total assets stood at SAR 132M with total equity of SAR 65M and total liabilities of SAR 67M.

Operating cash flow for 2025 was SAR -6M, representing a cash conversion ratio of -2.09 relative to net profit. Free cash flow was SAR -9M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR -2.09 arrived as operating cash. This indicates Low quality earnings based on the cash conversion ratio of -2.09.

Revenue growth from 2024 to 2025: +9.8%. Net profit growth over the same period: -78.4%. 3-year revenue CAGR: 31.3%. 3-year net profit CAGR: -25.8%.

Key financial ratios for 2025: Return on Equity 4.1%, Return on Assets 2.0%, Net Margin 2.9%, Debt to Equity 1.03.

In 2024, Lana Medical Co. reported revenue of SAR 84M and net profit of SAR 12M, compared to SAR 92M and SAR 3M respectively in 2025.